newsfilter
← Latest News
GlobeNewswire·

Pliant Therapeutics Provides Corporate Update and Reports Second Quarter 2024 Financial Results

Positive data from a 12-week Phase 2a PET imaging trial demonstrated reduced total lung collagen, improved FVC and reduced cough severity in IPF patients treated with bexotegrast Positive long-term data from